Health care biotech companies by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Biogen has the lowest figure of the 18 health care biotech companies ranked by P/B ratio, at 1.9, followed by Vaxcyte (3.5) and Neurocrine Biosciences (4.1). Figures as of 19 Nov 2026, 23:07 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
18
Lowest
Biogen1.9
Median
8.7
Combined market value
CHF 699.1B
Countries
5
Not ranked
6no P/B ratio on file

Market values as of .

All countries
Health Care
Biotech
CHF
Clear filters
Health care biotech companies by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care1.9CHF 30.8BCHF 208.56 1.70% down 49% up United States
2VaxcytePCVX · Health Care3.5CHF 7.8BCHF 49.25 0.27% down 23% up United States
3Neurocrine BiosciencesNBIX · Health Care4.1CHF 13.4BCHF 132.15 3.85% down 17% up United States
4RepligenRGEN · Health Care4.6CHF 9.2BCHF 143.71 1.38% down 12% up United States
5Bio-TechneTECH · Health Care5.3CHF 9.6BCHF 61.35 0.07% down 24% up United States
6Kymera TherapeuticsKYMR · Health Care6.3CHF 8.6BCHF 100.76 1.44% down 87% up United States
7Krystal BiotechKRYS · Health Care6.5CHF 7.9BCHF 266.53 0.15% up 54% up United States
8CG OncologyCGON · Health Care7.4CHF 6.2BCHF 69.12 2.38% up 97% up United States
9Twist BioscienceTWST · Health Care8.5CHF 6.4BCHF 94.20 4.07% down 346% up United States
10ExelixisEXEL · Health Care8.8CHF 13.6BCHF 55.56 3.60% down 63% up United States
11ImmunovantIMVT · Health Care10.2CHF 5.7BCHF 27.44 1.96% down 46% up United States
12ModernaMRNA · Health Care11.8CHF 68.1BCHF 168.22 1.29% up 780% up United States
13Revolution MedicinesRVMD · Health Care14.4CHF 29.1BCHF 134.55 0.24% down 129% up United States
14Gilead SciencesGILD · Health Care15.8CHF 174.3BCHF 140.54 1.45% down 35% up United States
15AmgenAMGN · Health Care16.5CHF 200.3BCHF 370.34 1.14% down 32% up United States
16Adaptive BiotechnologiesADPT · Health Care25.7CHF 3.8BCHF 23.67 1.44% down 74% up United States
17Scholar Rock HoldingSRRK · Health Care36.4CHF 5.2BCHF 42.51 4.94% up 26% up United States
18Kodiak SciencesKOD · Health Care499CHF 5.4BCHF 82.62 0.09% up 399% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8439 CHF). 6 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which health care biotech companies have the lowest P/B ratio?

Biogen (1.9), Vaxcyte (3.5) and Neurocrine Biosciences (4.1) have the lowest P/B ratio of the 18 health care biotech companies ranked here as of 19 Nov 2026, 23:07 UTC.

How many health care biotech companies are in this ranking?

18 are ranked by P/B ratio. 6 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these health care biotech companies worth together?

The 18 health care biotech companies ranked by P/B ratio have a combined market value of CHF 699.1B as of 19 Nov 2026, 23:07 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Health care biotech companies by P/B ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.